Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...
المؤلفون الرئيسيون: | Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2015
|
مواد مشابهة
-
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
حسب: Balendra, R, وآخرون
منشور في: (2015) -
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
حسب: Jones, A, وآخرون
منشور في: (2014) -
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
حسب: Balendra, R, وآخرون
منشور في: (2014) -
Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
حسب: Jones, A, وآخرون
منشور في: (2013) -
Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
حسب: Balendra, R, وآخرون
منشور في: (2013)